Cargando…
Predicting Radiation Resistance in Breast Cancer with Expression Status of Phosphorylated S6K1
Emerging evidence suggests that the mammalian target of rapamcyin (mTOR) pathway is associated with radio-resistance in cancer treatment. We hypothesised that phosphorylated ribosomal S6 kinase 1 (p-S6K1), a major downstream regulator of the mTOR pathway, may play a role in predicting radio-resistan...
Autores principales: | Choi, Jihye, Yoon, Yi Na, Kim, Nawon, Park, Chan Sub, Seol, Hyesil, Park, In-Chul, Kim, Hyun-Ah, Noh, Woo Chul, Kim, Jae-Sung, Seong, Min-Ki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971275/ https://www.ncbi.nlm.nih.gov/pubmed/31959810 http://dx.doi.org/10.1038/s41598-020-57496-8 |
Ejemplares similares
-
Predicting the Benefit of Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer Patients with Phosphorylated S6K1 Expression Status
por: Choi, Jihye, et al.
Publicado: (2019) -
pS6K1 as an efficacy marker of GnRH agonist with premenopausal breast cancer
por: Park, Chan Sub, et al.
Publicado: (2019) -
The Significance of p-AKT1 as a Prognostic Marker and Therapeutic Target in Patients With Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor-2-Positive Early Breast Cancer
por: Kim, Ji Yea, et al.
Publicado: (2022) -
Primary apocrine sweat gland carcinomas of the axilla: a report of two cases and a review of the literature
por: Seong, Min‐Ki, et al.
Publicado: (2015) -
Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancer
por: Kim, Yun Gyoung, et al.
Publicado: (2017)